About vivitide
vivitide is a company based in Gardner (United States) founded in 1983 was acquired by Biosynth Carbosynth in March 2022. The company has 94 employees. vivitide operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and Rameda, among others.
- Headquarter Gardner, United States
- Employees 94
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vivitide.com
- Social LinkedIn X
- Acquired by Biosynth Carbosynth (Mar 2022)
- Legal Name New England Peptide, Inc.
- Investors
- Employee Count94
- Acquired byBiosynth Carbosynth
(Mar 2022)
Investors in vivitide
vivitide has secured backing from 1 investor. Prominent investors backing the company include Biosynth Carbosynth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of drug discovery, manufacturing, supply chain, regulatory support, and other services | 1965 | carbosynth.com | Guildford, United Kingdom |
Investor details for vivitide
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of vivitide
4 people are tracked at vivitide (1 in leadership, 2 in board & advisors, 1 in team); the tracked headcount is 94.
| Name | Role | Group |
|---|---|---|
Martina Diekmann | CEO | Leadership |
Hansjoerg Streicher | Scientific Advisor | Board & advisors |
Chris Lawson | Scientific Advisor | Board & advisors |
Urs Spitz | Member Board Of Directors | Team |
Complete people profiles for vivitide
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of vivitide
2 dated milestones of vivitide across 39 years, from founding to its latest funding, stage changes and deals.
- Founded vivitide is founded.
- Exit Acquired by Biosynth Carbosynth.
Competitors of vivitide
vivitide operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and Rameda, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enzene.com | 2006 | Pune, India | $50M | 10 | Company specializing in development of Biosimilars | |
| hybio.com.cn | 1998 | Shenzhen, China | $15M | – | Polypeptide drugs and APIs are developed and manufactured. | |
| ambiopharm.com | 2006 | North Augusta, United States | $24M | 186 | CDMO and analytical services for peptide development are provided. | |
| ocelotbio.com | 2020 | San Diego, United States | $36M | – | Ocelot Bio is a CDMO specializing in peptide manufacturing services. | |
| ramedapharma.com | 1994 | Giza, Egypt | – | 2 | Developer and manufacturer of generic pharmaceuticals, nutraceuticals, food supplements and veterinary products | |
| micot.cn | 2007 | China | $72.16M | – | Drug R&D services for cardiovascular and metabolic diseases are provided. | |
| polypeptide.com | 1952 | Baar, Switzerland | – | – | Proprietary, GMP-grade, and non-GMP peptides are manufactured by PolyPeptide Labs. | |
| aperiambio.com | 2019 | United States | $13M | – | Industrial and therapeutic proteins are manufactured by Aperiam Bio. | |
| maruho.co.jp | 1915 | Osaka, Japan | – | – | Conducts R&D and manufactures ethical drugs for healthcare applications. |
Detailed competitors of vivitide
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vivitide
Complete news archive for vivitide
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to vivitide
10 companies that operate in the same segment as vivitide (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about vivitide
vivitide was founded in 1983.
vivitide is headquartered in Gardner, United States. It is registered at Gardner, Massachusetts, United States.
Martina Diekmann is the current CEO of vivitide.
vivitide has 94 employees.
Vivitide was founded in 1983 and is based in Gardner, United States. Services in the biotechnology sector are offered, focusing on drug development for neoantigen peptides and antibodies. Operations include peptide synthesis and antibody production to support pharmaceutical research. The company serves clients in the immuno-oncology field through specialized laboratory processes and expertise in custom biomolecule development.
vivitide's top competitors include Enzene Biosciences, Hybio Pharmaceutical and PolyPeptide.
vivitide has 1 investor. Key investors include Biosynth Carbosynth.
vivitide operates through New England Peptide, Inc..
Yes. vivitide was acquired by Biosynth Carbosynth in March 2022.